Evommune
Novel immunotherapy molecules for chronic inflammatory diseases
- Sector
- Biotech
- Headquarters
- PALO ALTO, CA
- Founded
- 2020
- Latest Form D
- $81.8M, Jan 2025
- Total capital
- $267M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $267M
- 4 Form D · last Jan 2025
- 22 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 4 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$81.8M
- Private capital raisedForm D · SEC · 3rd filing$57.5M
- Private capital raisedForm D · SEC · 2nd filing$115M
- Private capital raisedForm D · SEC · 1st filing$12.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Benjamin McGrawDirectorNamed in SEC Form D filings
- David CohenDirectorNamed in SEC Form D filings
- Derek DiRoccoDirectorNamed in SEC Form D filings
- Eugene BauerExecutive Officer, DirectorNamed in SEC Form D filings
- Felice Verduyn-van WeegenDirectorNamed in SEC Form D filings
- Francois BeaubienDirectorNamed in SEC Form D filings
Show all 13 people
- Gregory MossExecutive OfficerNamed in SEC Form D filings
- Janice DrewExecutive OfficerNamed in SEC Form D filings
- Jeegar PatelExecutive OfficerNamed in SEC Form D filings
- Kyle CarverExecutive OfficerNamed in SEC Form D filings
- Luis PenaExecutive Officer, DirectorNamed in SEC Form D filings
- Robert HopfnerDirectorNamed in SEC Form D filings
- Yuexin YuDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 4- PendingProtein Kinase C (pkc) Theta Inhibitor CompoundsUSPTOApplication PCTUS2024054220
- PendingProtein Kinase C (pkc) Theta Inhibitor CompoundsUSPTOApplication 63547300
- PendingProtein Kinase C (pkc) Theta Inhibitor CompoundsUSPTOApplication PCTUS2023028603
Show all 4 patent records
- Protein Kinase C (pkc) Theta Inhibitor CompoundsApplication PCTUS2024054220Pending
- Protein Kinase C (pkc) Theta Inhibitor CompoundsApplication 63547300Pending
- Protein Kinase C (pkc) Theta Inhibitor CompoundsApplication PCTUS2023028603Pending
- Protein Kinase C (pkc) Theta Inhibitor CompoundsApplication 63392058Pending
Related companies, and why
- CellanomeSimilar federal contract value in Biotech · null in contracts
- Rakuten Medical, Inc.Similar federal contract value in Biotech · null in contracts
- SeaStar Medical Holding CorpSimilar federal contract value in Biotech · null in contracts
- eGenesisSimilar federal contract value in Biotech · null in contracts
- Verona Pharma plcSimilar federal contract value in Biotech · null in contracts
- Capstan TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .